Research Overview: ANADROL (ANDROLIC) British Dispensary
ANADROL (ANDROLIC) British Dispensary is a pharmaceutical-grade oxymetholone formulation manufactured as an oral anabolic steroid compound for advanced laboratory research. This synthetic derivative of dihydrotestosterone represents a potent androgenic steroid with modifications at the 17α position that confer oral bioavailability in research models. Investigators studying Stroid UK Shop examine oxymetholone for its pronounced anabolic activity and unique binding characteristics at androgen receptor sites.
Research scientists evaluate this compound’s distinctive molecular structure, featuring a 17α-methyl modification that prevents hepatic metabolism while maintaining biological activity. The British Dispensary formulation provides researchers with consistent dosing for comparative studies examining androgenic pathway modulation. Laboratory investigations focus on oxymetholone’s ability to stimulate protein synthesis, nitrogen retention mechanisms, and erythropoietin production pathways in controlled experimental conditions.
Laboratory Applications
Researchers studying oxymetholone compounds investigate its effects on androgen receptor activation, transcriptional regulation of muscle-building proteins, and erythropoietic stimulation mechanisms. Scientific studies examine this compound’s interaction with androgen response elements and its influence on IGF-1 expression in tissue culture systems. Laboratory protocols evaluate oxymetholone’s binding affinity compared to testosterone and other anabolic steroids in receptor assays.
Advanced research applications include examining this compound’s effects on satellite cell activation, myonuclear domain expansion, and collagen synthesis pathways. Investigators studying metabolic effects analyse oxymetholone’s influence on glucose uptake mechanisms and lipid metabolism regulation. Research focusing on selective androgen modulators uses oxymetholone as a reference standard for comparative potency studies. Studies examining peptide hormone interactions investigate potential synergistic effects with growth factors and anabolic peptides.
Compound Specifications
| Active Compound | Oxymetholone |
|---|---|
| CAS Number | 434-07-1 |
| Molecular Formula | C₂₁H₃₂O₃ |
| Molecular Weight | 332.48 g/mol |
| Manufacturer | British Dispensary |
| Form | Oral tablets |
| Storage | Room temperature, dry conditions |
Research Use Compliance
This product is manufactured exclusively for in-vitro laboratory research and analytical testing purposes. Not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with applicable regulations governing anabolic steroid research in their jurisdiction.
